The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises

The yes-associated protein (YAP) and the transcriptional coactivator with PDZ-binding motif (TAZ) are transcriptional coactivators, members of the Hippo signaling pathway, which play a critical role in cell growth regulation, embryonic development, regeneration, proliferation, and cancer origin and progression. The mechanism involves the nuclear binding of the un-phosphorylated YAP/TAZ complex to release the transcriptional enhanced associate domain (TEAD) from its repressors. The active ternary complex is responsible for the aforementioned biological effects. Overexpression of YAP/TAZ has been reported in cancer stem cells and tumor resistance. The resistance involves chemotherapy, targeted therapy, and immunotherapy. This review provides an overview of YAP/TAZ pathways’ role in carcinogenesis and tumor microenvironment. Potential therapeutic alternatives are also discussed.

• Autores: Ortega, Ángel; Vera, Ivana; Diaz, Maria P.; Navarro, Carla; Rojas, Milagros; Torres, Wheeler; Parra, Heliana; Salazar, Juan; De Sanctis, Juan B.; Bermúdez, Valmore
• Fecha de publicación: 2022
• Institución: Universidad Simón Bolívar
• Repositorio: Repositorio Digital USB
• Idioma: eng
• OAI Identifier: oai:bonga.unisimon.edu.co:20.500.12442/9506
• Acceso en línea: https://hdl.handle.net/20.500.12442/9506; https://doi.org/10.3390/ijms23010430
• Palabra clave: YAP/TAZ; Hippo signaling pathway; carcinogenesis; Tumor microenvironment; neoplastic stem cells; cell proliferation; drug resistance; chemoresistance; immunotherapy
• Rights: openAccess
• License: Attribution-NonCommercial-NoDerivatives 4.0 Internacional